Results 241 to 250 of about 172,432 (312)

Social Determinants of Health and Health‐Related Quality of Life: The Potential Mediating Role of Social Activities, Access to Medical Services, and Access to Social Services

Australian Journal of Social Issues, EarlyView.
ABSTRACT This study explored the mediating influences of access to social activities, social services, and health and medical services on the relationship between social determinants of health and health‐related quality of life. A survey of 602 adults was conducted in a regional area of Australia.
Candice Oster, Ashleigh Powell, Claire Hutchinson, Richard Leibbrandt, Svetlana Bogomolova   +4 more
wiley   +1 more source

Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey. [PDF]

Curr Oncol
Başkurt K, Akdoğan O, Sağdıç Karateke Y, Deliktaş Onur İ, Uyar GC, Yeşilbaş E, Yazıcı O, Yıldız B, Karaçin C, Çakmak Öksüzoğlu ÖB, Sütçüoğlu O.   +10 more
europepmc   +1 more source

Owning Home, Finding Belonging: Relational Meanings of Homeownership for Migrant Healthcare Workers in Australia

Australian Journal of Social Issues, EarlyView.
ABSTRACT Migrant healthcare workers in Australia find themselves at the centre of three intersecting concerns, often presented as ‘crises’ in contemporary discourse: the ‘care crisis’, the ‘housing crisis’ and the ‘migration crisis.’ Yet their own perspectives on these issues are rarely foregrounded. This paper explores the role of homeownership in the
Leah Williams Veazey
wiley   +1 more source

Bi-functional anti-LAG-3-IL-2c enhances immune checkpoint inhibitor and CAR T-cell therapy for cancer. [PDF]

iScience
Huang F, Huang J, Ye F, Chen SC, Huang WC, Hua B, Li EY, Jiang J, Kwan J, Lin H, Shi W, He H, Yang M, Fu Q, Lu B, Zhong Z.   +15 more
europepmc   +1 more source

In vivo CAR-T therapy: latest updates from the 2025 ASH annual meeting. [PDF]

Biomark Res
Wang S, Kong R, Zhong G, Yang X, Zhou X.
europepmc   +1 more source

Rapidly evolved PD-1 for enhance receptor and checkpoint inhibitor in immunotherapy. [PDF]

Mol Ther Oncol
Mei X, Li X, Wu Y, Fu D, Zhang F, Yan T, Gu W, Gao B.   +7 more
europepmc   +1 more source

The in vivo revolution in CAR-T therapy medicinal products: challenges and regulatory prospects. [PDF]

Signal Transduct Target Ther
Lu J, Cui J, Dong J, Yan L, Wang X, Zhou D, Lu S, Wei W.   +7 more
europepmc   +1 more source

Proof-of-Concept Evaluation of Primary Human FAP-CAR-NK Cells Targeting Activated Fibroblasts in Pulmonary Fibrosis. [PDF]

Int J Mol Sci
Wu G, Ling Z, Lin W, Wang Y, Liu X, Wang J.   +5 more
europepmc   +1 more source

Predictors of Relapse and Post‐Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome‐Negative B‐ALL

American Journal of Hematology, EarlyView.
Sankalp Arora, Hagop Kantarjian, Koji Sasaki, Nitin Jain, Zhouxuan Li, Wei Qiao, Sanam Loghavi, Guilin Tang, Caitlin Rausch, Farhad Ravandi, Fadi G. Haddad, Jayastu Senapati, Guillermo Montalban Bravo, Alexandre Bazinet, Rita Khouri, Rebecca Garris, Guillermo Garcia‐Manero, Nicholas J. Short, Elias Jabbour   +18 more
wiley   +1 more source